Wcn24-385 Predicting Patient Response to Standard-of-Care Therapies in Glomerular Diseases

Glucocorticoids and calcineurin inhibitors (CNI) are part of KDIGO guidelines for treatment of steroid resistant glomerular diseases. Despite widespread use, predicting whether a patient will respond to therapy remains elusive. Given toxicities associated with prolonged CNI use, identifying patients who are both likely and unlikely to respond to these therapies presents an opportunity to improve overall patient care.